Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump

Journal of Hypertension

Volumn 30, Issue 9, 2012, Pages 1817-1826

  Fedorova, Olga V ^a   Kashkin, Vladimir A ^a   Zakharova, Irina O ^a   Lakatta, Edward G ^a   Bagrov, Alexei Y ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

aging; cyclic guanosine monophosphate; dietary sodium; hypertension; marinobufagenin; Na K ATPase; natriuretic peptides; protein kinase G; salt sensitivity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; CYCLIC GMP; MARINOBUFAGENIN; PHOSPHODIESTERASE V; SODIUM CHLORIDE;

AGE; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; IN VITRO STUDY; KIDNEY MEDULLA; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

EID: 84865501660     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328356399b     Document Type: Article

References (35)

1. Khaw KT, Barrett-Connor E. Increasing sensitivity of blood pressure to dietary sodium and potassium with increasing age. A population study using casual urine specimens. Am J Hypertens 1990; 3:505-511. (Pubitemid 20380204)
2. Sacks FM, Svetkey LP, Vollmer MW, Appel LJ, Bray GA, Harsha D, et al., DASH Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344:3-10. (Pubitemid 32064838)
3. Cowley AW Jr. Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr 1997; 65 (2 Suppl):587S-593S. (Pubitemid 27063058)
4. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology and novel therapeutic targets. Pharmacol Rev 2009; 61:9-38.
5. Bełtowski J, Wójcicka G. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002; 8:RA39-RA52. (Pubitemid 34218479)
6. Richards AM. Natriuretic peptides: update on Peptide release, bioactivity, and clinical use. Hypertension 2007; 50:25-30. (Pubitemid 46986002)
7. Bailly C. Effect of luminal atrial natriuretic peptide on chloride reabsorption in mouse cortical thick ascending limb: inhibition by endothelin. J Am Soc Nephrol 2000; 11:1791-1797.
8. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994; 266:R1244-R1250.
9. Aperia A, Holtback U, Syren ML, Svensson LB, Fryckstedt J, Greengard P. Activation/deactivation of renal Na( +),K( +)-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994; 8:436-469.
10. Fedorova OB, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 2006; 48:1160-1168. (Pubitemid 44772722)
11. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 2003; 12:527-532. (Pubitemid 37083114)
12. Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous ligand of a-1 Na/K-ATPase, is a marker of congestive heart failure severity. J Hypertens 2002; 20:1189-1194. (Pubitemid 34913639)
13. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. An endogenous ligand of a-1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride dependent hypertension. Circulation 2002; 105:1122-1127. (Pubitemid 34213289)
14. Bagrov AY, Agalakova NI, Kashkin VA, Fedorova OV. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats. Am J Hypertens 2009; 22:559-563.
15. Lin CS, Liu X, Tu R, Chow S, Lue TF. Age-related decrease of protein kinase G activation in vascular smooth muscle cells. Biochem Biophys Res Commun 2001; 287:244-248. (Pubitemid 32912489)
16. Scavone C, Munhoz CD, Kawamoto EM, Glezer I, de Sá Lima L, Marcourakis T, Markus RP. Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na,K-ATPase activity. Neurobiol Aging 2005; 26:907-916. (Pubitemid 40249494)
17. Cui R, Iso H, Yamagishi K, Ohira T, Tanigawa T, Kitamura A, et al. Relationship of urinary cGMP excretion with aging and menopausal status in a general population. J Atheroscler Thromb 2009; 16:457-462.
18. Feschenko MS, Sweadner KJ. Phosphorylation of Na,K-ATPase by protein kinase C at Ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis. J Biol Chem 1997; 272:17726-17733. (Pubitemid 27311211)
19. Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, et al. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/KATPase inhibition in lowers blood pressure in NaCl-sensitive hypertension. J Hypertens 2008; 26:2414-2425.
20. Fedorova OV, Lakatta EG, Bagrov AY. Differential effects of acute NaCl loading on endogenous ouabain-like and marinobufagenin-like ligands of the sodium pump in Dahl hypertensive rats. Circulation 2000; 102:3009-3014.
21. Yamada K, Goto A, Nagoshi H, Terano Y, Omata M. Elevation of ouabain-like compound levels with hypertonic sodium chloride load in rat plasma and tissues. Hypertension 1997; 30:94-98. (Pubitemid 27306353)
22. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl loaded Dahl-S rats. J Hypertens 2005; 23:1515-1523. (Pubitemid 41104823)
23. Anderson DE, Fedorova OV, Morrell CH, Kashkin VA, Bagrov AY, Lakatta EG. Endogenous sodium pump inhibitors are linked to ageassociated increases in salt sensitivity of blood pressure in normotensives. Am J Physiol Regul Integr Physiol 2008; 294:R1248-R1254. (Pubitemid 351490645)
24. Kawamoto EM, Munhoz CD, Lepsch LB, de Sá Lima L, Glezer I, Markus RP, et al. Age-related changes in cerebellar phosphatase-1 reduce Na,K-ATPase activity. Neurobiol Aging 2008; 29:1712-1720.
25. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998; 275:F633-F650.
26. Silva E, Pinto V, Simão S, Serrão MP, Afonso J, Amaral J, et al. Renal aging in WKY rats: changes in Na +,K +-ATPase function and oxidative stress. Exp Gerontol 2010; 45:977-983.
27. Hennessy JF. Vascular tissue (Na,K)ATPase activity and aging in the F344 rat. Mech Ageing Dev 1988; 43:153-159.
28. Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix M-T, Lakatta EG, Bagrov AY. Reduction in myocardial PKC b2, Na/K-ATPase sensitivity to marinobufagenin and blood pressure in response to cicletanine. Hypertension 2003; 41:505-511. (Pubitemid 36314624)
29. Fotis H, Tatjanenko LV, Vasilets LA. Phosphorylation of the alphasubunits of the Na,ATPase from mammalian kidneys and Xenopus oocytes by cGMP-dependent protein kinase results instimulation of ATPase activity. Eur J Biochem 1999; 260:904-910. (Pubitemid 29148659)
30. Eklöf AC, Holtbäck U, Svennilson J, Fienberg A, Greengard P, Aperia A. Increased blood pressure and loss of ANP-induced natriuresis in mice lacking DARPP-32 gene. Clin Exp Hypertens 2001; 23:449-460. (Pubitemid 32673356)
31. Citterio L, Simonini M, Zagato L, Salvi E, Delli Carpini S, Lanzani C, et al. Genes involved in vasoconstriction and vasodilation system affect saltsensitive hypertension. PLoS One 2011; 6:e19620.
32. Fedorova OV, Shapiro JI, Bagrov AY. Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochim Biophys Acta 2010; 1802:1230-1236.
33. Haller ST, Kennedy DJ, Shidyak A, Budny GV, Malhotra D, Fedorova OV, et al. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am J Hypertens 2012; 25:690-696.
34. Susic D, Frohlich ED. The aging hypertensive heart: a brief update. Nat Clin Pract Cardiovasc Med 2008; 5:104-110.
35. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006; 69:318-328. (Pubitemid 43098788)